Cargando…
Are rare cancer survivors at elevated risk of subsequent new cancers?
BACKGROUND: Although rare cancers account for 27% of cancer diagnoses in the US, there is insufficient research on survivorship issues in these patients. An important issue cancer survivors face is an elevated risk of being diagnosed with new primary cancers. The primary aim of this analysis was to...
Autores principales: | Finkelstein, Dianne M., Horick, Nora K., Ramchandani, Ritesh, Boyd, Kristina L., Rana, Huma Q., Bychkovsky, Brittany L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385466/ https://www.ncbi.nlm.nih.gov/pubmed/30791872 http://dx.doi.org/10.1186/s12885-019-5358-1 |
Ejemplares similares
-
Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer
por: Lowery, Jan T, et al.
Publicado: (2011) -
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023) -
Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022) -
Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?
por: Bognar, Cinthia Leite Frizzera Borges, et al.
Publicado: (2016)